BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21543616)

  • 1. Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.
    Sleiman SF; Langley BC; Basso M; Berlin J; Xia L; Payappilly JB; Kharel MK; Guo H; Marsh JL; Thompson LM; Mahishi L; Ahuja P; MacLellan WR; Geschwind DH; Coppola G; Rohr J; Ratan RR
    J Neurosci; 2011 May; 31(18):6858-70. PubMed ID: 21543616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription.
    Fernández-Guizán A; Mansilla S; Barceló F; Vizcaíno C; Núñez LE; Morís F; González S; Portugal J
    Chem Biol Interact; 2014 Aug; 219():123-32. PubMed ID: 24907531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.
    Chatterjee S; Zaman K; Ryu H; Conforto A; Ratan RR
    Ann Neurol; 2001 Mar; 49(3):345-54. PubMed ID: 11261509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
    Mandal S; Davie JR
    J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
    Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
    Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mithramycin selectively attenuates DNA-damage-induced neuronal cell death.
    Makarevich O; Sabirzhanov B; Aubrecht TG; Glaser EP; Polster BM; Henry RJ; Faden AI; Stoica BA
    Cell Death Dis; 2020 Jul; 11(7):587. PubMed ID: 32719328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.
    Ferrante RJ; Ryu H; Kubilus JK; D'Mello S; Sugars KL; Lee J; Lu P; Smith K; Browne S; Beal MF; Kristal BS; Stavrovskaya IG; Hewett S; Rubinsztein DC; Langley B; Ratan RR
    J Neurosci; 2004 Nov; 24(46):10335-42. PubMed ID: 15548647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons.
    Ryu H; Lee J; Zaman K; Kubilis J; Ferrante RJ; Ross BD; Neve R; Ratan RR
    J Neurosci; 2003 May; 23(9):3597-606. PubMed ID: 12736330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.
    Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
    Cancer Biol Ther; 2010 Jun; 9(12):1008-16. PubMed ID: 20372080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
    Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
    Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.
    Ahn SY; Cho CH; Park KG; Lee HJ; Lee S; Park SK; Lee IK; Koh GY
    Am J Pathol; 2004 May; 164(5):1663-72. PubMed ID: 15111313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites.
    Lee TJ; Jung EM; Lee JT; Kim S; Park JW; Choi KS; Kwon TK
    Mol Cancer Ther; 2006 Nov; 5(11):2737-46. PubMed ID: 17121920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p53-mediated transcriptional responses by mithramycin A.
    Koutsodontis G; Kardassis D
    Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
    Jia Z; Gao Y; Wang L; Li Q; Zhang J; Le X; Wei D; Yao JC; Chang DZ; Huang S; Xie K
    Cancer Res; 2010 Feb; 70(3):1111-9. PubMed ID: 20086170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
    Lu S; Archer MC
    Int J Cancer; 2010 Jan; 126(2):416-25. PubMed ID: 19621387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.
    Liu R; Zhi X; Zhou Z; Zhang H; Yang R; Zou T; Chen C
    Sci Rep; 2018 Jan; 8(1):1138. PubMed ID: 29348684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
    Shin T; Sumiyoshi H; Matsuo N; Satoh F; Nomura Y; Mimata H; Yoshioka H
    Arch Biochem Biophys; 2005 Mar; 435(2):291-302. PubMed ID: 15708372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.
    Langley B; D'Annibale MA; Suh K; Ayoub I; Tolhurst A; Bastan B; Yang L; Ko B; Fisher M; Cho S; Beal MF; Ratan RR
    J Neurosci; 2008 Jan; 28(1):163-76. PubMed ID: 18171934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
    Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
    Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer.
    Choi ES; Nam JS; Jung JY; Cho NP; Cho SD
    Sci Rep; 2014 Nov; 4():7162. PubMed ID: 25418289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.